Evonik

Leading Beyond Chemistry

Company Presentation Q3 2022

Key messages Q3 2022

Solid results in an increasingly challenging market environment

Solid results in an increasingly challenging market environment:

Adj. EBITDA of €615 m in Q3 - supported by a strong Specialty Additives performance (+8% yoy)

Volumes decline, pricing holding up: Double-digit price increases across all growth divisions resulting in ongoing successful pass-on of higher variable costs

Cash generation picking up with FCF of €288 m in Q3;

further significant NWC improvement expected in Q4 to achieve ~30% cash conversion for the full year

Outlook for FY 2022 confirmed: Adj. EBITDA between €2.5 and 2.6 bn

Structural support for 2023: Resilient & regionally balanced portfolio setup, progress in Performance Materials divestment, high visibility on energy costs & gas supply, contingency measure toolbox in implementation

2 November / December 2022 | Evonik Q3 2022 Company Presentation

Table of contents

  1. Evonik at a glance
  2. Strategy
  3. Capital allocation & financial targets
  4. Financials Q3 2022

3 November / December 2022 | Evonik Q3 2022 Company Presentation

Leading Beyond Chemistry - Our purpose

Evonik on the way to become a best-in-class specialty chemicals company

Video "We are Evonik"

Leading …

… Beyond …

… Chemistry

  • Leading market positions in 80% of our business
  • Leading key financial indicators
  • Connecting skills and perspectives
  • Develop solutions together with partners
  • Sustainability key driver of growth
  • Clear focus on specialty chemicals
  • Target 100% specialty portfolio

4 November / December 2022 | Evonik Q3 2022 Company Presentation

Evonik well equipped as "Enabler of Sustainable Change"

Portfolio circled around our four "Sustainability Focus Areas"

ENSURE HEALTH

& WELL-BEING

DRUG DELIVERY SYSTEMS

Advanced oral & parenteral

drug delivery systems

(e.g. mRNA LNP)

SPECIALTY ADDITIVES

for environmentally-friendly solutions, e.g. water-based artificial leather

FIGHT

FUTURE MOBILITY

CLIMATE CHANGE

Lightweight solutions

Solutions for hybrid & full battery cars

ECO-SOLUTIONS

Specialty peroxides solutions

Membranes for gas separation

CIRCULAR ECONOMY

Circular plastic & circular polyurethanes additive solutions

DRIVE

CIRCULARITY

BIO-BASED SOLUTIONS

Bio-based & fully biodegradable surfactants

Natural active cosmetics ingredients

SUSTAINABLE NUTRITION

Omega-3 fatty acids from natural marine algae

Gut health solutions

SAFEGUARD

ECOSYSTEMS

5 November / December 2022 | Evonik Q3 2022 Company Presentation

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Evonik Industries AG published this content on 15 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 November 2022 15:51:03 UTC.